1:34
SOHO 2018 | The importance of quickly spotting the signs of AML
Srdan Verstovsek
4:19
SOHO 2018 | Intervening on time: how hypomethylating agents can prevent transition to AML
Srdan Verstovsek
3:05
SOHO 2018 | Current research in elderly, untreated AML: venetoclax combinations
Marina Konopleva
2:57
SOHO 2018 | Genetic biomarkers of response to venetoclax in AML
Marina Konopleva
3:20
SOHO 2018 | Venetoclax combinations effective in elderly AML
Marina Konopleva
1:39
SOHO 2018 | Current landscape and future directions for lower-risk MDS treatment
David Steensma
1:06
ESH AL 2018 | Is there hope for treating TP53-mutated MDS?
Mark Levis
1:12
ASCO 2018 | Hypomethylating agents for low risk MDS
Eunice Wang
1:58
ESH AL 2018 | Maintenance therapy strategies to reduce relapse in AML
Charles Craddock
2:50
EHA 2018 | Epigenetic therapies in AML: current and future landscape
Andrew Wei
1:54
ASH 2017 | Promising results for venetoclax across multiple hematological malignancies
Giovanni Martinelli
1:32
ESH AL 2018 | Encouraging patients to participate in AML trials
Eytan Stein
2:20
ESH AL 2018 | The complications of treating elderly patients with AML
Gail Roboz
2:33
ASH 2017 | Decitabine dosing regimens in older AML patients: 5-day vs. 10-day, is there a difference?
Farhad Ravandi
1:55
ASH 2017 | Ruxolitinib plus decitabine in post-MPN AML
Farhad Ravandi
2:01
ASH 2017 | AML: data to look forward to in 2018 and beyond
Richard Stone
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals